Drugs for Malaria Industry Research Report 2024
Summary
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria.
The Drugs for Malaria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Malaria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drugs for Malaria companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria.
The Drugs for Malaria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Malaria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drugs for Malaria companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Drugs for Malaria by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Aryl Aminoalcohol Compounds
2.2.3 Antifolate Compounds
2.2.4 Artemisinin Compounds
2.3 Drugs for Malaria by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Prevention
2.3.3 Treatment
2.3.4 Others
2.4 Assumptions and Limitations
3 DRUGS FOR MALARIA BREAKDOWN DATA BY TYPE
3.1 Global Drugs for Malaria Historic Market Size by Type (2019-2024)
3.2 Global Drugs for Malaria Forecasted Market Size by Type (2025-2030)
4 DRUGS FOR MALARIA BREAKDOWN DATA BY APPLICATION
4.1 Global Drugs for Malaria Historic Market Size by Application (2019-2024)
4.2 Global Drugs for Malaria Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Drugs for Malaria Market Perspective (2019-2030)
5.2 Global Drugs for Malaria Growth Trends by Region
5.2.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Drugs for Malaria Historic Market Size by Region (2019-2024)
5.2.3 Drugs for Malaria Forecasted Market Size by Region (2025-2030)
5.3 Drugs for Malaria Market Dynamics
5.3.1 Drugs for Malaria Industry Trends
5.3.2 Drugs for Malaria Market Drivers
5.3.3 Drugs for Malaria Market Challenges
5.3.4 Drugs for Malaria Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Drugs for Malaria Players by Revenue
6.1.1 Global Top Drugs for Malaria Players by Revenue (2019-2024)
6.1.2 Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
6.2 Global Drugs for Malaria Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Drugs for Malaria Head office and Area Served
6.4 Global Drugs for Malaria Players, Product Type & Application
6.5 Global Drugs for Malaria Players, Date of Enter into This Industry
6.6 Global Drugs for Malaria Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Drugs for Malaria Market Size (2019-2030)
7.2 North America Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Drugs for Malaria Market Size by Country (2019-2024)
7.4 North America Drugs for Malaria Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Drugs for Malaria Market Size (2019-2030)
8.2 Europe Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Drugs for Malaria Market Size by Country (2019-2024)
8.4 Europe Drugs for Malaria Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Malaria Market Size (2019-2030)
9.2 Asia-Pacific Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Drugs for Malaria Market Size by Country (2019-2024)
9.4 Asia-Pacific Drugs for Malaria Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Drugs for Malaria Market Size (2019-2030)
10.2 Latin America Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Drugs for Malaria Market Size by Country (2019-2024)
10.4 Latin America Drugs for Malaria Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Malaria Market Size (2019-2030)
11.2 Middle East & Africa Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024)
11.4 Middle East & Africa Drugs for Malaria Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Cipla
12.1.1 Cipla Company Information
12.1.2 Cipla Business Overview
12.1.3 Cipla Revenue in Drugs for Malaria Business (2019-2024)
12.1.4 Cipla Drugs for Malaria Product Portfolio
12.1.5 Cipla Recent Developments
12.2 Guilin Pharmaceutical
12.2.1 Guilin Pharmaceutical Company Information
12.2.2 Guilin Pharmaceutical Business Overview
12.2.3 Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2019-2024)
12.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
12.2.5 Guilin Pharmaceutical Recent Developments
12.3 IPCA Laboratories
12.3.1 IPCA Laboratories Company Information
12.3.2 IPCA Laboratories Business Overview
12.3.3 IPCA Laboratories Revenue in Drugs for Malaria Business (2019-2024)
12.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
12.3.5 IPCA Laboratories Recent Developments
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Revenue in Drugs for Malaria Business (2019-2024)
12.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
12.4.5 GlaxoSmithKline Recent Developments
12.5 Mylan Labs
12.5.1 Mylan Labs Company Information
12.5.2 Mylan Labs Business Overview
12.5.3 Mylan Labs Revenue in Drugs for Malaria Business (2019-2024)
12.5.4 Mylan Labs Drugs for Malaria Product Portfolio
12.5.5 Mylan Labs Recent Developments
12.6 Roche
12.6.1 Roche Company Information
12.6.2 Roche Business Overview
12.6.3 Roche Revenue in Drugs for Malaria Business (2019-2024)
12.6.4 Roche Drugs for Malaria Product Portfolio
12.6.5 Roche Recent Developments
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Business Overview
12.7.3 Novartis Revenue in Drugs for Malaria Business (2019-2024)
12.7.4 Novartis Drugs for Malaria Product Portfolio
12.7.5 Novartis Recent Developments
12.8 Sanofi Aventis
12.8.1 Sanofi Aventis Company Information
12.8.2 Sanofi Aventis Business Overview
12.8.3 Sanofi Aventis Revenue in Drugs for Malaria Business (2019-2024)
12.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
12.8.5 Sanofi Aventis Recent Developments
12.9 Ajanta Pharma
12.9.1 Ajanta Pharma Company Information
12.9.2 Ajanta Pharma Business Overview
12.9.3 Ajanta Pharma Revenue in Drugs for Malaria Business (2019-2024)
12.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
12.9.5 Ajanta Pharma Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Drugs for Malaria by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Aryl Aminoalcohol Compounds
2.2.3 Antifolate Compounds
2.2.4 Artemisinin Compounds
2.3 Drugs for Malaria by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Prevention
2.3.3 Treatment
2.3.4 Others
2.4 Assumptions and Limitations
3 DRUGS FOR MALARIA BREAKDOWN DATA BY TYPE
3.1 Global Drugs for Malaria Historic Market Size by Type (2019-2024)
3.2 Global Drugs for Malaria Forecasted Market Size by Type (2025-2030)
4 DRUGS FOR MALARIA BREAKDOWN DATA BY APPLICATION
4.1 Global Drugs for Malaria Historic Market Size by Application (2019-2024)
4.2 Global Drugs for Malaria Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Drugs for Malaria Market Perspective (2019-2030)
5.2 Global Drugs for Malaria Growth Trends by Region
5.2.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Drugs for Malaria Historic Market Size by Region (2019-2024)
5.2.3 Drugs for Malaria Forecasted Market Size by Region (2025-2030)
5.3 Drugs for Malaria Market Dynamics
5.3.1 Drugs for Malaria Industry Trends
5.3.2 Drugs for Malaria Market Drivers
5.3.3 Drugs for Malaria Market Challenges
5.3.4 Drugs for Malaria Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Drugs for Malaria Players by Revenue
6.1.1 Global Top Drugs for Malaria Players by Revenue (2019-2024)
6.1.2 Global Drugs for Malaria Revenue Market Share by Players (2019-2024)
6.2 Global Drugs for Malaria Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Drugs for Malaria Head office and Area Served
6.4 Global Drugs for Malaria Players, Product Type & Application
6.5 Global Drugs for Malaria Players, Date of Enter into This Industry
6.6 Global Drugs for Malaria Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Drugs for Malaria Market Size (2019-2030)
7.2 North America Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Drugs for Malaria Market Size by Country (2019-2024)
7.4 North America Drugs for Malaria Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Drugs for Malaria Market Size (2019-2030)
8.2 Europe Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Drugs for Malaria Market Size by Country (2019-2024)
8.4 Europe Drugs for Malaria Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Malaria Market Size (2019-2030)
9.2 Asia-Pacific Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Drugs for Malaria Market Size by Country (2019-2024)
9.4 Asia-Pacific Drugs for Malaria Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Drugs for Malaria Market Size (2019-2030)
10.2 Latin America Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Drugs for Malaria Market Size by Country (2019-2024)
10.4 Latin America Drugs for Malaria Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Malaria Market Size (2019-2030)
11.2 Middle East & Africa Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024)
11.4 Middle East & Africa Drugs for Malaria Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Cipla
12.1.1 Cipla Company Information
12.1.2 Cipla Business Overview
12.1.3 Cipla Revenue in Drugs for Malaria Business (2019-2024)
12.1.4 Cipla Drugs for Malaria Product Portfolio
12.1.5 Cipla Recent Developments
12.2 Guilin Pharmaceutical
12.2.1 Guilin Pharmaceutical Company Information
12.2.2 Guilin Pharmaceutical Business Overview
12.2.3 Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2019-2024)
12.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
12.2.5 Guilin Pharmaceutical Recent Developments
12.3 IPCA Laboratories
12.3.1 IPCA Laboratories Company Information
12.3.2 IPCA Laboratories Business Overview
12.3.3 IPCA Laboratories Revenue in Drugs for Malaria Business (2019-2024)
12.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
12.3.5 IPCA Laboratories Recent Developments
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Revenue in Drugs for Malaria Business (2019-2024)
12.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
12.4.5 GlaxoSmithKline Recent Developments
12.5 Mylan Labs
12.5.1 Mylan Labs Company Information
12.5.2 Mylan Labs Business Overview
12.5.3 Mylan Labs Revenue in Drugs for Malaria Business (2019-2024)
12.5.4 Mylan Labs Drugs for Malaria Product Portfolio
12.5.5 Mylan Labs Recent Developments
12.6 Roche
12.6.1 Roche Company Information
12.6.2 Roche Business Overview
12.6.3 Roche Revenue in Drugs for Malaria Business (2019-2024)
12.6.4 Roche Drugs for Malaria Product Portfolio
12.6.5 Roche Recent Developments
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Business Overview
12.7.3 Novartis Revenue in Drugs for Malaria Business (2019-2024)
12.7.4 Novartis Drugs for Malaria Product Portfolio
12.7.5 Novartis Recent Developments
12.8 Sanofi Aventis
12.8.1 Sanofi Aventis Company Information
12.8.2 Sanofi Aventis Business Overview
12.8.3 Sanofi Aventis Revenue in Drugs for Malaria Business (2019-2024)
12.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
12.8.5 Sanofi Aventis Recent Developments
12.9 Ajanta Pharma
12.9.1 Ajanta Pharma Company Information
12.9.2 Ajanta Pharma Business Overview
12.9.3 Ajanta Pharma Revenue in Drugs for Malaria Business (2019-2024)
12.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
12.9.5 Ajanta Pharma Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drugs for Malaria Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drugs for Malaria Revenue Market Share by Type (2018-2023)
Table 7. Global Drugs for Malaria Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drugs for Malaria Revenue Market Share by Type (2024-2029)
Table 9. Global Drugs for Malaria Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drugs for Malaria Revenue Market Share by Application (2018-2023)
Table 11. Global Drugs for Malaria Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drugs for Malaria Revenue Market Share by Application (2024-2029)
Table 13. Global Drugs for Malaria Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drugs for Malaria Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drugs for Malaria Market Share by Region (2018-2023)
Table 16. Global Drugs for Malaria Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drugs for Malaria Market Share by Region (2024-2029)
Table 18. Drugs for Malaria Market Trends
Table 19. Drugs for Malaria Market Drivers
Table 20. Drugs for Malaria Market Challenges
Table 21. Drugs for Malaria Market Restraints
Table 22. Global Top Drugs for Malaria Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drugs for Malaria Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drugs for Malaria Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drugs for Malaria, Headquarters and Area Served
Table 26. Global Drugs for Malaria Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drugs for Malaria by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 45. Cipla Company Detail
Table 46. Cipla Business Overview
Table 47. Cipla Drugs for Malaria Product
Table 48. Cipla Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 49. Cipla Recent Development
Table 50. Guilin Pharmaceutical Company Detail
Table 51. Guilin Pharmaceutical Business Overview
Table 52. Guilin Pharmaceutical Drugs for Malaria Product
Table 53. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 54. Guilin Pharmaceutical Recent Development
Table 55. IPCA Laboratories Company Detail
Table 56. IPCA Laboratories Business Overview
Table 57. IPCA Laboratories Drugs for Malaria Product
Table 58. IPCA Laboratories Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 59. IPCA Laboratories Recent Development
Table 60. GlaxoSmithKline Company Detail
Table 61. GlaxoSmithKline Business Overview
Table 62. GlaxoSmithKline Drugs for Malaria Product
Table 63. GlaxoSmithKline Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 64. GlaxoSmithKline Recent Development
Table 65. Mylan Labs Company Detail
Table 66. Mylan Labs Business Overview
Table 67. Mylan Labs Drugs for Malaria Product
Table 68. Mylan Labs Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 69. Mylan Labs Recent Development
Table 70. Roche Company Detail
Table 71. Roche Business Overview
Table 72. Roche Drugs for Malaria Product
Table 73. Roche Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Novartis Company Detail
Table 76. Novartis Business Overview
Table 77. Novartis Drugs for Malaria Product
Table 78. Novartis Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Sanofi Aventis Company Detail
Table 81. Sanofi Aventis Business Overview
Table 82. Sanofi Aventis Drugs for Malaria Product
Table 83. Sanofi Aventis Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 84. Sanofi Aventis Recent Development
Table 85. Ajanta Pharma Company Detail
Table 86. Ajanta Pharma Business Overview
Table 87. Ajanta Pharma Drugs for Malaria Product
Table 88. Ajanta Pharma Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 89. Ajanta Pharma Recent Development
Table 90. Cipla Company Information
Table 91. Cipla Business Overview
Table 92. Cipla Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 93. Cipla Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 94. Cipla Recent Development
Table 95. Guilin Pharmaceutical Company Information
Table 96. Guilin Pharmaceutical Business Overview
Table 97. Guilin Pharmaceutical Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 98. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 99. Guilin Pharmaceutical Recent Development
Table 100. IPCA Laboratories Company Information
Table 101. IPCA Laboratories Business Overview
Table 102. IPCA Laboratories Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 103. IPCA Laboratories Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 104. IPCA Laboratories Recent Development
Table 105. GlaxoSmithKline Company Information
Table 106. GlaxoSmithKline Business Overview
Table 107. GlaxoSmithKline Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 108. GlaxoSmithKline Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 109. GlaxoSmithKline Recent Development
Table 110. Mylan Labs Company Information
Table 111. Mylan Labs Business Overview
Table 112. Mylan Labs Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 113. Mylan Labs Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 114. Mylan Labs Recent Development
Table 115. Roche Company Information
Table 116. Roche Business Overview
Table 117. Roche Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 118. Roche Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 119. Roche Recent Development
Table 120. Novartis Company Information
Table 121. Novartis Business Overview
Table 122. Novartis Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 123. Novartis Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 124. Novartis Recent Development
Table 125. Sanofi Aventis Company Information
Table 126. Sanofi Aventis Business Overview
Table 127. Sanofi Aventis Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 128. Sanofi Aventis Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 129. Sanofi Aventis Recent Development
Table 130. Ajanta Pharma Company Information
Table 131. Ajanta Pharma Business Overview
Table 132. Ajanta Pharma Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 133. Ajanta Pharma Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 134. Ajanta Pharma Recent Development
Table 135. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drugs for Malaria Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drugs for Malaria Revenue Market Share by Type (2018-2023)
Table 7. Global Drugs for Malaria Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drugs for Malaria Revenue Market Share by Type (2024-2029)
Table 9. Global Drugs for Malaria Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drugs for Malaria Revenue Market Share by Application (2018-2023)
Table 11. Global Drugs for Malaria Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drugs for Malaria Revenue Market Share by Application (2024-2029)
Table 13. Global Drugs for Malaria Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drugs for Malaria Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drugs for Malaria Market Share by Region (2018-2023)
Table 16. Global Drugs for Malaria Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drugs for Malaria Market Share by Region (2024-2029)
Table 18. Drugs for Malaria Market Trends
Table 19. Drugs for Malaria Market Drivers
Table 20. Drugs for Malaria Market Challenges
Table 21. Drugs for Malaria Market Restraints
Table 22. Global Top Drugs for Malaria Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drugs for Malaria Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drugs for Malaria Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drugs for Malaria, Headquarters and Area Served
Table 26. Global Drugs for Malaria Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drugs for Malaria by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drugs for Malaria Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drugs for Malaria Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drugs for Malaria Market Size by Country (2024-2029) & (US$ Million)
Table 45. Cipla Company Detail
Table 46. Cipla Business Overview
Table 47. Cipla Drugs for Malaria Product
Table 48. Cipla Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 49. Cipla Recent Development
Table 50. Guilin Pharmaceutical Company Detail
Table 51. Guilin Pharmaceutical Business Overview
Table 52. Guilin Pharmaceutical Drugs for Malaria Product
Table 53. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 54. Guilin Pharmaceutical Recent Development
Table 55. IPCA Laboratories Company Detail
Table 56. IPCA Laboratories Business Overview
Table 57. IPCA Laboratories Drugs for Malaria Product
Table 58. IPCA Laboratories Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 59. IPCA Laboratories Recent Development
Table 60. GlaxoSmithKline Company Detail
Table 61. GlaxoSmithKline Business Overview
Table 62. GlaxoSmithKline Drugs for Malaria Product
Table 63. GlaxoSmithKline Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 64. GlaxoSmithKline Recent Development
Table 65. Mylan Labs Company Detail
Table 66. Mylan Labs Business Overview
Table 67. Mylan Labs Drugs for Malaria Product
Table 68. Mylan Labs Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 69. Mylan Labs Recent Development
Table 70. Roche Company Detail
Table 71. Roche Business Overview
Table 72. Roche Drugs for Malaria Product
Table 73. Roche Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Novartis Company Detail
Table 76. Novartis Business Overview
Table 77. Novartis Drugs for Malaria Product
Table 78. Novartis Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Sanofi Aventis Company Detail
Table 81. Sanofi Aventis Business Overview
Table 82. Sanofi Aventis Drugs for Malaria Product
Table 83. Sanofi Aventis Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 84. Sanofi Aventis Recent Development
Table 85. Ajanta Pharma Company Detail
Table 86. Ajanta Pharma Business Overview
Table 87. Ajanta Pharma Drugs for Malaria Product
Table 88. Ajanta Pharma Revenue in Drugs for Malaria Business (2017-2022) & (US$ Million)
Table 89. Ajanta Pharma Recent Development
Table 90. Cipla Company Information
Table 91. Cipla Business Overview
Table 92. Cipla Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 93. Cipla Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 94. Cipla Recent Development
Table 95. Guilin Pharmaceutical Company Information
Table 96. Guilin Pharmaceutical Business Overview
Table 97. Guilin Pharmaceutical Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 98. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 99. Guilin Pharmaceutical Recent Development
Table 100. IPCA Laboratories Company Information
Table 101. IPCA Laboratories Business Overview
Table 102. IPCA Laboratories Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 103. IPCA Laboratories Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 104. IPCA Laboratories Recent Development
Table 105. GlaxoSmithKline Company Information
Table 106. GlaxoSmithKline Business Overview
Table 107. GlaxoSmithKline Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 108. GlaxoSmithKline Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 109. GlaxoSmithKline Recent Development
Table 110. Mylan Labs Company Information
Table 111. Mylan Labs Business Overview
Table 112. Mylan Labs Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 113. Mylan Labs Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 114. Mylan Labs Recent Development
Table 115. Roche Company Information
Table 116. Roche Business Overview
Table 117. Roche Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 118. Roche Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 119. Roche Recent Development
Table 120. Novartis Company Information
Table 121. Novartis Business Overview
Table 122. Novartis Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 123. Novartis Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 124. Novartis Recent Development
Table 125. Sanofi Aventis Company Information
Table 126. Sanofi Aventis Business Overview
Table 127. Sanofi Aventis Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 128. Sanofi Aventis Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 129. Sanofi Aventis Recent Development
Table 130. Ajanta Pharma Company Information
Table 131. Ajanta Pharma Business Overview
Table 132. Ajanta Pharma Drugs for Malaria Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million)
Table 133. Ajanta Pharma Revenue in Drugs for Malaria Business (2018-2023) & (US$ Million) Portfolio
Table 134. Ajanta Pharma Recent Development
Table 135. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drugs for Malaria Product Picture
Figure 5. Global Drugs for Malaria Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drugs for Malaria Market Share by Type: 2022 VS 2029
Figure 7. Aryl Aminoalcohol Compounds Product Picture
Figure 8. Antifolate Compounds Product Picture
Figure 9. Artemisinin Compounds Product Picture
Figure 10. Global Drugs for Malaria Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Drugs for Malaria Market Share by Application: 2022 VS 2029
Figure 12. Prevention Product Picture
Figure 13. Treatment Product Picture
Figure 14. Others Product Picture
Figure 15. Global Drugs for Malaria Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Drugs for Malaria Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Drugs for Malaria Market Share by Region: 2022 VS 2029
Figure 18. Global Drugs for Malaria Market Share by Players in 2022
Figure 19. Global Drugs for Malaria Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Drugs for Malaria Market Share by Country (2018-2029)
Figure 24. United States Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Drugs for Malaria Market Share by Country (2018-2029)
Figure 28. Germany Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Drugs for Malaria Market Share by Country (2018-2029)
Figure 36. China Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Drugs for Malaria Market Share by Country (2018-2029)
Figure 44. Mexico Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Drugs for Malaria Market Share by Country (2018-2029)
Figure 48. Turkey Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Cipla Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 52. Guilin Pharmaceutical Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 53. IPCA Laboratories Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 55. Mylan Labs Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 56. Roche Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 58. Sanofi Aventis Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 59. Ajanta Pharma Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drugs for Malaria Product Picture
Figure 5. Global Drugs for Malaria Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drugs for Malaria Market Share by Type: 2022 VS 2029
Figure 7. Aryl Aminoalcohol Compounds Product Picture
Figure 8. Antifolate Compounds Product Picture
Figure 9. Artemisinin Compounds Product Picture
Figure 10. Global Drugs for Malaria Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Drugs for Malaria Market Share by Application: 2022 VS 2029
Figure 12. Prevention Product Picture
Figure 13. Treatment Product Picture
Figure 14. Others Product Picture
Figure 15. Global Drugs for Malaria Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Drugs for Malaria Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Drugs for Malaria Market Share by Region: 2022 VS 2029
Figure 18. Global Drugs for Malaria Market Share by Players in 2022
Figure 19. Global Drugs for Malaria Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Drugs for Malaria Market Share by Country (2018-2029)
Figure 24. United States Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Drugs for Malaria Market Share by Country (2018-2029)
Figure 28. Germany Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Drugs for Malaria Market Share by Country (2018-2029)
Figure 36. China Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Drugs for Malaria Market Share by Country (2018-2029)
Figure 44. Mexico Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Drugs for Malaria Market Share by Country (2018-2029)
Figure 48. Turkey Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Drugs for Malaria Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Cipla Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 52. Guilin Pharmaceutical Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 53. IPCA Laboratories Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 55. Mylan Labs Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 56. Roche Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 58. Sanofi Aventis Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
Figure 59. Ajanta Pharma Revenue Growth Rate in Drugs for Malaria Business (2018-2023)
